| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 464.88B | 460.32B | 430.19B | 425.23B | 366.19B | 344.36B |
| Gross Profit | 158.39B | 151.61B | 133.79B | 135.02B | 113.69B | 112.67B |
| EBITDA | 61.88B | 61.13B | 53.91B | 54.78B | 47.70B | 52.27B |
| Net Income | 29.50B | 29.69B | 26.67B | 26.10B | 23.75B | 27.58B |
Balance Sheet | ||||||
| Total Assets | 574.59B | 606.59B | 577.09B | 547.11B | 512.87B | 497.29B |
| Cash, Cash Equivalents and Short-Term Investments | 166.97B | 176.81B | 155.67B | 158.62B | 185.49B | 204.93B |
| Total Debt | 23.82B | 3.53B | 3.76B | 2.69B | 2.06B | 1.73B |
| Total Liabilities | 130.83B | 144.87B | 139.65B | 139.91B | 134.01B | 125.97B |
| Stockholders Equity | 396.87B | 405.85B | 387.77B | 364.15B | 343.12B | 342.33B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 40.66B | 6.60B | -6.56B | 8.47B | 36.88B |
| Operating Cash Flow | 0.00 | 57.50B | 43.35B | 19.39B | 28.70B | 49.49B |
| Investing Cash Flow | 0.00 | -22.68B | -19.97B | -30.09B | -25.49B | -15.82B |
| Financing Cash Flow | 0.00 | -26.50B | -23.66B | -21.31B | -27.11B | -7.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥16.64B | 2.31 | ― | 2.30% | 9.86% | 119.10% | |
81 Outperform | ¥19.68B | 9.88 | ― | 3.46% | 3.87% | 5.89% | |
76 Outperform | ¥513.58B | 11.76 | 8.51% | 2.25% | 3.33% | 9.57% | |
72 Outperform | ¥175.86B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
67 Neutral | ¥66.85B | 31.55 | 1.61% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥28.02B | 3.93 | ― | 2.94% | 0.41% | -51.02% |